Format
Sort by

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 276

1.

Longitudinal measurement and hierarchical classification framework for the prediction of Alzheimer's disease.

Huang M, Yang W, Feng Q, Chen W; Alzheimer’s Disease Neuroimaging Initiative..

Sci Rep. 2017 Jan 12;7:39880. doi: 10.1038/srep39880.

2.

Multimodal characterization of older APOE2 carriers reveals selective reduction of amyloid load.

Grothe MJ, Villeneuve S, Dyrba M, Bartrés-Faz D, Wirth M; Alzheimer's Disease Neuroimaging Initiative..

Neurology. 2017 Jan 6. pii: 10.1212/WNL.0000000000003585. doi: 10.1212/WNL.0000000000003585. [Epub ahead of print]

PMID:
28062720
3.

Let's Not SPRINT to Judgment About New Blood Pressure Goals.

Lewis CE, Johnson KC, Rahman M, Sink KM, Ambrosius WT.

Ann Intern Med. 2016 Dec 20;165(12):889. doi: 10.7326/L16-0441. No abstract available.

PMID:
27992902
4.

Dynapenia and Metabolic Health in Obese and Nonobese Adults Aged 70 Years and Older: The LIFE Study.

Aubertin-Leheudre M, Anton S, Beavers DP, Manini TM, Fielding R, Newman A, Church T, Kritchevsky SB, Conroy D, McDermott MM, Botoseneanu A, Hauser ME, Pahor M; LIFE Research Group..

J Am Med Dir Assoc. 2016 Nov 30. pii: S1525-8610(16)30468-6. doi: 10.1016/j.jamda.2016.10.001. [Epub ahead of print]

PMID:
27914851
5.

Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer's pathology.

Schmitz TW, Nathan Spreng R; Alzheimer's Disease Neuroimaging Initiative..

Nat Commun. 2016 Nov 4;7:13249. doi: 10.1038/ncomms13249.

6.

Bayesian model reveals latent atrophy factors with dissociable cognitive trajectories in Alzheimer's disease.

Zhang X, Mormino EC, Sun N, Sperling RA, Sabuncu MR, Yeo BT; Alzheimer’s Disease Neuroimaging Initiative..

Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):E6535-E6544.

7.

Moderate Alcohol Consumption and Chronic Disease: The Case for a Long-Term Trial.

Mukamal KJ, Clowry CM, Murray MM, Hendriks HF, Rimm EB, Sink KM, Adebamowo CA, Dragsted LO, Lapinski PS, Lazo M, Krystal JH.

Alcohol Clin Exp Res. 2016 Nov;40(11):2283-2291. doi: 10.1111/acer.13231. Review.

PMID:
27688006
8.

APOE Genotypes Associate With Cognitive Performance but Not Cerebral Structure: Diabetes Heart Study MIND.

Palmer Allred ND, Raffield LM, Hardy JC, Hsu FC, Divers J, Xu J, Smith SC, Hugenschmidt CE, Wagner BC, Whitlow CT, Sink KM, Maldjian JA, Williamson JD, Bowden DW, Freedman BI.

Diabetes Care. 2016 Dec;39(12):2225-2231.

PMID:
27703028
9.

Adiposity is inversely associated with hippocampal volume in African Americans and European Americans with diabetes.

Hsu FC, Yuan M, Bowden DW, Xu J, Smith SC, Wagenknecht LE, Langefeld CD, Divers J, Register TC, Carr JJ, Williamson JD, Sink KM, Maldjian JA, Freedman BI.

J Diabetes Complications. 2016 Nov - Dec;30(8):1506-1512. doi: 10.1016/j.jdiacomp.2016.08.012.

PMID:
27615667
10.

Morphometricity as a measure of the neuroanatomical signature of a trait.

Sabuncu MR, Ge T, Holmes AJ, Smoller JW, Buckner RL, Fischl B; Alzheimer's Disease Neuroimaging Initiative..

Proc Natl Acad Sci U S A. 2016 Sep 27;113(39):E5749-56. doi: 10.1073/pnas.1604378113.

11.

Predictors of Change in Physical Function in Older Adults in Response to Long-Term, Structured Physical Activity: The LIFE Study.

Layne AS, Hsu FC, Blair SN, Chen SH, Dungan J, Fielding RA, Glynn NW, Hajduk AM, King AC, Manini TM, Marsh AP, Pahor M, Pellegrini CA, Buford TW; LIFE Study Investigators..

Arch Phys Med Rehabil. 2017 Jan;98(1):11-24.e3. doi: 10.1016/j.apmr.2016.07.019.

PMID:
27568165
12.

Polygenic risk of Alzheimer disease is associated with early- and late-life processes.

Mormino EC, Sperling RA, Holmes AJ, Buckner RL, De Jager PL, Smoller JW, Sabuncu MR; Alzheimer's Disease Neuroimaging Initiative..

Neurology. 2016 Aug 2;87(5):481-8. doi: 10.1212/WNL.0000000000002922.

PMID:
27385740
13.

APOL1 renal-risk variants associate with reduced cerebral white matter lesion volume and increased gray matter volume.

Freedman BI, Gadegbeku CA, Bryan RN, Palmer ND, Hicks PJ, Ma L, Rocco MV, Smith SC, Xu J, Whitlow CT, Wagner BC, Langefeld CD, Hawfield AT, Bates JT, Lerner AJ, Raj DS, Sadaghiani MS, Toto RD, Wright JT Jr, Bowden DW, Williamson JD, Sink KM, Maldjian JA, Pajewski NM, Divers J; African American–Diabetes Heart Study MIND (AA-DHS MIND) and Systolic Blood Pressure Intervention Trial (SPRINT) Research Groups..

Kidney Int. 2016 Aug;90(2):440-9. doi: 10.1016/j.kint.2016.04.027.

PMID:
27342958
14.

Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis.

Iturria-Medina Y, Sotero RC, Toussaint PJ, Mateos-Pérez JM, Evans AC; Alzheimer’s Disease Neuroimaging Initiative..

Nat Commun. 2016 Jun 21;7:11934. doi: 10.1038/ncomms11934.

15.

A semi-mechanism approach based on MRI and proteomics for prediction of conversion from mild cognitive impairment to Alzheimer's disease.

Liu H, Zhou X, Jiang H, He H, Liu X; Alzheimer’s Disease Neuroimaging Initiative..

Sci Rep. 2016 Jun 7;6:26712. doi: 10.1038/srep26712.

16.

Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer's disease cohorts.

Tan L, Wang HF, Tan MS, Tan CC, Zhu XC, Miao D, Yu WJ, Jiang T, Tan L, Yu JT; Alzheimer’s Disease Neuroimaging Initiative..

Sci Rep. 2016 May 27;6:26027. doi: 10.1038/srep26027.

17.

Hospitalizations During a Physical Activity Intervention in Older Adults at Risk of Mobility Disability: Analyses from the Lifestyle Interventions and Independence for Elders Randomized Clinical Trial.

Marsh AP, Applegate WB, Guralnik JM, Jack Rejeski W, Church TS, Fielding RA, Gill TM, King AC, Kritchevsky SB, Manini TM, McDermott MM, Newman AB, Stowe CL, Walkup MP, Pahor M, Miller ME; LIFE Study Investigators..

J Am Geriatr Soc. 2016 May;64(5):933-43. doi: 10.1111/jgs.14114.

PMID:
27225353
18.

Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial.

Williamson JD, Supiano MA, Applegate WB, Berlowitz DR, Campbell RC, Chertow GM, Fine LJ, Haley WE, Hawfield AT, Ix JH, Kitzman DW, Kostis JB, Krousel-Wood MA, Launer LJ, Oparil S, Rodriguez CJ, Roumie CL, Shorr RI, Sink KM, Wadley VG, Whelton PK, Whittle J, Woolard NF, Wright JT Jr, Pajewski NM; SPRINT Research Group..

JAMA. 2016 Jun 28;315(24):2673-82. doi: 10.1001/jama.2016.7050.

19.

Accelerating rates of cognitive decline and imaging markers associated with β-amyloid pathology.

Insel PS, Mattsson N, Mackin RS, Schöll M, Nosheny RL, Tosun D, Donohue MC, Aisen PS, Jagust WJ, Weiner MW; Alzheimer's Disease Neuroimaging Initiative..

Neurology. 2016 May 17;86(20):1887-96. doi: 10.1212/WNL.0000000000002683.

PMID:
27164667
20.

The impact of PICALM genetic variations on reserve capacity of posterior cingulate in AD continuum.

Xu W, Wang HF, Tan L, Tan MS, Tan CC, Zhu XC, Miao D, Yu WJ, Jiang T, Tan L, Yu JT; Alzheimer’s Disease Neuroimaging Initiative Group..

Sci Rep. 2016 Apr 27;6:24480. doi: 10.1038/srep24480.

Items per page

Supplemental Content

Loading ...
Support Center